Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
China Isotope & Radiation Corp. ( (HK:1763) ) has provided an announcement.
China Isotope & Radiation Corporation announced that its subsidiary, Sichuan CNNC Tongyuan Technology Co., Ltd., has obtained a radiation safety license for its new R&D and production base, the largest in Asia. This development positions CIRC to enhance its production capabilities and expand its market offerings, with plans to introduce new production lines and increase its product portfolio to meet diverse market demands.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation (CIRC) operates in the radiation technology industry, focusing on the development and production of radioactive sources. The company offers a wide range of products featuring over 70 nuclides and provides services such as radioactive source recycling and irradiation. CIRC serves various sectors including industry, agriculture, medicine, national defense, and aerospace, catering to both domestic and international markets.
Average Trading Volume: 523,228
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.7B
See more insights into 1763 stock on TipRanks’ Stock Analysis page.